Pages that link to "Q33341317"
Jump to navigation
Jump to search
The following pages link to Radioimmunotherapy of small-volume disease of metastatic colorectal cancer (Q33341317):
Displaying 50 items.
- Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria (Q24569648) (← links)
- Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers (Q24792155) (← links)
- The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA (Q28730117) (← links)
- Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma (Q33367113) (← links)
- Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer (Q33379811) (← links)
- Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer (Q33408024) (← links)
- Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma (Q33412585) (← links)
- Ligand-targeted therapeutics in anticancer therapy (Q34152775) (← links)
- Tumour therapy with radionuclides: assessment of progress and problems. (Q34185077) (← links)
- Clinical applications of newer radionuclide therapies (Q34505512) (← links)
- Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma (Q35059542) (← links)
- Advancing role of radiolabeled antibodies in the therapy of cancer (Q35109775) (← links)
- Ligand liposomes and boron neutron capture therapy (Q35128595) (← links)
- Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis (Q35509695) (← links)
- Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies (Q35670238) (← links)
- Radioimmunotherapy with engineered antibodies (Q35681517) (← links)
- Radiolabelled monoclonal antibodies in the treatment of metastatic cancer (Q35840380) (← links)
- Anti-carcinoembryonic antigen immunity. (Q35875288) (← links)
- Recent advances in pretargeted radioimmunotherapy (Q36050639) (← links)
- Radioimmunotherapy and colorectal cancer (Q36058561) (← links)
- A method to predict response of cell populations to cocktails of chemotherapeutics and radiopharmaceuticals: validation with daunomycin, doxorubicin, and the alpha particle emitter (210)Po (Q36103417) (← links)
- Arming antibodies for cancer therapy (Q36160583) (← links)
- Targeted cancer therapy using radiolabeled monoclonal antibodies (Q36200161) (← links)
- CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas (Q36211422) (← links)
- Current status of cancer therapy with radiolabeled monoclonal antibody (Q36257924) (← links)
- Tailoring antibodies for radionuclide delivery (Q36349687) (← links)
- Antibody-guided radiation therapy of cancer (Q36366528) (← links)
- Advances in radioimmunotherapy in the age of molecular engineering and pretargeting (Q36391426) (← links)
- Systemic targeted radionuclide therapy: potential new areas (Q36595714) (← links)
- Targeted radionuclide therapy for solid tumors: an overview (Q36595724) (← links)
- Targeted therapy in nuclear medicine--current status and future prospects. (Q36792133) (← links)
- Radionuclide therapy of cancer with radiolabeled antibodies (Q36822715) (← links)
- Technological advances in radioimmunotherapy (Q36835227) (← links)
- Synergistic antitumor activity of immune strategies combined with radiation. (Q36849636) (← links)
- The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis (Q36903804) (← links)
- Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy. (Q37002044) (← links)
- Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccines (Q37146209) (← links)
- Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin (Q37226204) (← links)
- Is there a future role for immunoscintigraphy in the diagnosis of colorectal carcinoma? (Q37371818) (← links)
- CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates (Q37402888) (← links)
- Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals (Q37689951) (← links)
- Radioactive Antibodies: A Historical Review of Selective Targeting and Treatment of Cancer (Q37796519) (← links)
- Clinical radioimmunotherapy--the role of radiobiology. (Q37953785) (← links)
- The new golden era for radioimmunotherapy: not just for lymphomas anymore (Q38072815) (← links)
- General overview of radioimmunotherapy of solid tumors (Q38103579) (← links)
- Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments (Q38703704) (← links)
- Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice (Q39635616) (← links)
- Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. (Q39751543) (← links)
- Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake (Q39781933) (← links)
- Biodistribution of 211At-labeled humanized monoclonal antibody A33. (Q40084788) (← links)